Dr. Todd Grande on MSN
Officer shoots officer trial reveals gun condition that doesn’t add up | Fitzsimmons update/analysis
A detailed breakdown of motive, warning signs, and relationship dynamics linked to the tragic revenge allegations.
Skye P. Marshall confirms Matlock Season 2 will resolve the Wellbrexa case, as Olympia backs Matty and new dynamics emerge ...
Systemic Lupus Erythematosus Clinical Trial Pipeline Accelerates as 120+ Pharma Companies Rigorously Developing Drugs for Market Entry | DelveInsight The SLE clinical trial analysis report delivers ...
Matty takes over Shae’s defense in court as bribery allegations are challenged, while Olympia investigates leads tied to the ...
Drs. Yunda Huang, Maria Lemos, Bo Zhang and Karsten Eichholz were recently awarded coveted R01 grants from the National ...
Through their achievements, thought leadership, and commitment to their clients and communities, these attorneys represent ...
A research team led by Potsdam-based bioinformatician Prof. Dr. Zoran Nikoloski has developed a computational approach and an ...
CEO Dietrich Pauls framed 2025 as a milestone year across DM199, describing it as “a recombinant form of the naturally occurring KLK1 protein” and emphasizing the company’s belief that its mechanism ...
Japanese rail conglomerate Tokyu is exploring deploying data centers along one of its railway routes. Tokyu Corporation, Tokyu Electric Railway Co., iTSCOM, and Tokyu Construction Co., last week ...
AngioDynamics (NASDAQ:ANGO) reported fiscal 2026 third-quarter results that management described as “strong across the board, ...
The potential to create personalised digital “twins” of your brain and body is a hot topic in neuroscience and medicine today ...
Management raised FY2026 net sales guidance to $313.5 million to $315.5 million (from $312 million to $314 million) and raised adjusted EBITDA guidance to $10 million to $12 million (from $8 million ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results